SUBSCRIBE: Print / Digital / eNewsletter
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.
Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.
How new research shows the importance of targeted drug therapies.
The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.
Virtual care comes to the pharmacy chain.
Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes
Clinical trials hold great promise for advancing healthcare—but only if the right patients are found.
Why a new study that actively tracks patient quality-of-life could be a big advancement in clinical trials.
Where and how greater numbers of pharmacists are getting involved at health systems.
A look at recent developments in treatment and the cost implications of various autoimmune diseases.
How the digitalization of pharmacy is transforming patient care.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
